Maternal and Neonatal Perinatal Outcomes of Singleton Pregnancies in Advanced-Age Women Undergoing IVF/ICSI-ET Compared with Spontaneous Conception: A Retrospective Propensity Score Matched Cohort Study
Jingxia Mao,Guibo Yang,Qin Su,Zhonghong Zeng,Jueying Lin,Lin Kong,Lidun Zhang,Lidan Liu,Yihua Yang,Hongbo Wu
DOI: https://doi.org/10.2147/ijgm.s490959
IF: 2.145
2024-11-16
International Journal of General Medicine
Abstract:Jingxia Mao, 1, 2, &ast Guibo Yang, 1, 3, &ast Qin Su, 1, 4, &ast Zhonghong Zeng, 1 Jueying Lin, 2 Lin Kong, 3 Lidun Zhang, 4 Lidan Liu, 1 Yihua Yang, 1 Hongbo Wu 1 1 Guangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China; 2 Department of Obstetrics, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China; 3 Department of Obstetrics, The Maternity and Child Health Care of Guangxi Zhuang Autonomous Region, Nanning, People's Republic of China; 4 Department of Obstetrics, The First People's Hospital of Yulin, Yulin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hongbo Wu; Yihua Yang, Guangxi Reproductive Medical Center, The First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China, Email ; Objective: To assess the safety and efficiency of in vitro fertilization/ intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) on maternal and neonatal perinatal outcomes in women (≥ 40y) with singleton pregnancies. Methods: This multi-center retrospective cohort study, carried out from January 2018 to June 2023, enrolled 1762 women (≥ 40y) with singleton pregnancies of at least 28 weeks. Participants were divided into two groups: the IVF/ICSI-ET group (204 cases) and the spontaneous conception (SC) group (1558 cases). After 1:2 propensity score matching (PSM), the two groups were compared for maternal and neonatal outcomes. The SC group (1558 cases) was further divided by age into the < 43 years group (1195 cases) and the ≥ 43 years group (363 cases) for subgroup analysis. Results: Adverse maternal and neonatal outcomes were comparable between the IVF/ICSI-ET group and the SC group, with a higher cesarean section rate (78% vs 67.5%, P =0.013), an increased maternal ICU admissions rate (5.5% vs 1.3%, P =0.008), and a lower birth defects rate (1.1% vs 4.6%, P =0.037) in the IVF/ICSI-ET group. Subgroup analysis showed that women aged ≥ 43 years had higher incidences of gestational diabetes, gestational hypertension, cesarean section, and neonatal asphyxia compared to women aged < 43 years. Conclusion: This study indicated IVF/ICSI-ET is relatively safe for women ≥ 40 years with singleton pregnancies. However, advanced maternal age deteriorated maternal and neonatal outcomes, and IVF/ICSI-ET further heightened the risk of cesarean section and maternal ICU admissions. Therefore, enhanced care and vigilance are crucial for women over 40 undergoing IVF/ICSI-ET. Keywords: in-vitro fertilization, intracytoplasmic sperm injection, advanced maternal age, maternal outcomes, neonatal outcomes As society progresses and attitudes towards fertility evolve, coupled with the widespread adoption of in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET) techniques, the global average age of pregnant women has been steadily increasing. 1 This trend has greatly increased the proportion of pregnancies in women aged 35 years or older, which was defined as advanced maternal age by the International Federation of Gynecology and Obstetrics (FIGO). Advanced maternal age was not only associated with increased risks of adverse pregnancy outcomes for both the mother and fetus 1 but also with increased IVF/ICSI-ET use, 2 due to decreased ovarian reserve and poor egg quality. 3 Therefore, an accurate assessment of the impact of IVF/ICSI-ET on maternal and neonatal outcomes in women of advanced age is crucial. Since the birth of the first IVF baby in 1978, IVF/ICSI-ET technology has seen continuous improvements, 4 leading to higher pregnancy and live birth rates. However, the use of superovulation simultaneously to mature multiple oocytes, along with the in vitro micromanipulation and culture for fertilization and early embryo development, has sparked controversy regarding their potential to increase adverse maternal-fetal outcomes. Previously, a review paper summarized that fresh embryo transfer was associated with a higher risk of small gestational age, low birth weight, and premature birth, while frozen embryo transfer was linked with large gestational age infants and preeclampsia, and ICSI may lead to a higher risk of premature rupture of membranes, 5 birth defects and the transfer of poor semen quality to male offspring. 6 But numerous studies suggested that subfertility, whether or not using IVF/ICSI-ET to achieve a pregna -Abstract Truncated-
medicine, general & internal